2026 Annual Novogene DE Sequencing Symposium

Event Information

Register Here

Novogene Sequencing Symposium:

"Multi-Omics for Medical Research"

Join us on May 7th, 2026 for the Annual Novogene Sequencing Symposium, a dynamic event dedicated to the latest advances in sequencing.

Join leading researchers, scientists, and innovators for an engaging day exploring the latest advances in Next-Generation Sequencing (NGS) in Medical research.

Designed to spark new ideas and support your research, the event will explore the rapidly evolving landscape of NGS and its transformative impact across genomics and life sciences.

With distinguished speakers from academia and industry, you’ll gain valuable perspectives on how NGS technologies are accelerating discovery and shaping the future of genomics. Expect engaging talks, collaborative discussions, and plenty of opportunities to network with peers who share your passion for advancing science.

Be part of the conversation, exchange ideas, and discover what’s next in sequencing.

Date: Thursday 7th May, 2026

Timings (see full agenda below): 09:30 - 16:30 CET

Location: IZB, Am Klopferspitz 19, 82152 Planegg, Germany

Lunch and refreshments provided - Everyone welcome.

Tickets are free however registration is required.

Registration is now closed - thank you

Confirmed Speakers

Yuanyuan Chen

Novogene Europe

Yuanyuan Chen Ph.D has served as the managing director at Novogene Gmbh since 2024. She joined Novogene in 2016, and has worked in sales, supports and BU management.

Dr. Stephan Emmrich

Leukemia-Research Group

Universitätsklinikum Frankfurt

Dr. Stephan Emmrich is a Junior Research Group Leader at Goethe University Frankfurt in the leukemia research team of Prof. Jan-Henning Klusmann. His research focuses on hematopoietic stem cell biology, ageing, and leukemic transformation.

Prof. Simon T. Schäfer

TUM School of Medicine and Health

Prof. Schäfer develops stem cell–based technologies to create 3D human brain models for personalized research on brain disorders and repair.

He studied medicine and biomedical sciences in Greifswald and San Diego, earned his PhD in 2015, and completed a postdoc at the Salk Institute. He is now Assistant Professor for Advanced Organoid Technologies at TUM and a member of the Center for Organoid Systems (COS).

Prof. Dr. Roland Rad

TUM School of Medicine and Health

Prof. Roland Rad is Director of the Institute of Molecular Oncology and Functional Genomics at TUM. His research focuses on tumour evolution, including malignant transformation, metastasis, and drug resistance.

His team develops genetic technologies and disease models to study complex biological systems and advance new cancer therapies.

Dr. Martin Seifert

10x Genomics

Dr. Martin Seifert is a Senior Science and Technology Provider at 10x Genomics with a background in transcriptomics. He began at the Technical University of Munich, co-authored a landmark human transcriptome paper (2008), and later founded Connexome, a clinical multimodal analysis consultancy. With 50+ publications, he focuses on integrating single-cell and spatial technologies with clinical data.

Prof. Max Nieuwdorp

AmsterdamUMC

Dr. Stijn Meijnikman

AmsterdamUMC

Prof. Max Nieuwdorp is Chair of Diabetes and Vascular Medicine at Amsterdam UMC. His research focuses on the role of the gut microbiota in diabetes and its complications, translating discoveries into new therapies. He has published over 360 papers and received major grants, including an ERC Advanced Grant.

He is joined in conversation by Dr. Stijn Meijnikman.

Adriana Michels, PhD

Proteomic Sciences

Olink, part of Thermo Fisher Scientific

Dr. Michael Hannig

Proteomic Sciences Olink, part of Thermo Fisher Scientific

Adriana Michels, PhD is a Field Application Scientist at Olink Proteomics (part of Thermo Fisher Scientific), supporting large-scale proteomics studies for biomarker discovery and precision medicine, with a PhD in Molecular Cancer Biology and over a decade of experience in translational research.

Michael is a Business Development Manager at Thermo Fisher Scientific, supporting protein biomarker discovery in Austria and Southern Bavaria. He holds a PhD in Microbiology and has a background in genomics and multi-omics technologies across Europe.

Dr. Dimitar Petrov

PacBio

Valérie Marot-Lassauzaie

PacBio

Dr. Dimitar Petrov is an Application Scientist at PacBio (since 2022) in Munich, with a background in RNA research, biotechnology, and a PhD in microbiology and metabolic engineering.

Valérie Marot-Lassauzaie is a Field Application Bioinfomatics Support at PacBio, specializing in long-read sequencing applications, including full-length RNA sequencing and single-cell variant detection.

Agenda